Suchergebnisse - "Byun, Ja Min"

PubPharm (5)

1

A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients

enthalten in: Cancer research and treatment | 2024

von Byun, J. | Shin, J. | Kim, S. | +9

2

Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma

enthalten in: British journal of haematology | 2023

von Shin, J. | Lee, J. | Lee, G. | +11

3

Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease

enthalten in: Journal of hematology & oncology | 2022

von Byun, J. | Min, C. | Kim, K. | +5

4

Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients : a prospective phase II multi-center study in Korea

enthalten in: Current problems in cancer | 2022

von Byun, J. | Kim, S. | Koh, Y. | +9

5

Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM

enthalten in: PloS one | 2022

von Park, H. | Byun, J. | Yoon, S. | +5

1
[1]